{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:19:02Z","timestamp":1761707942688,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,10,1]],"date-time":"2006-10-01T00:00:00Z","timestamp":1159660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ibroneuroscience.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2006,10]]},"DOI":"10.1016\/j.neuroscience.2006.06.052","type":"journal-article","created":{"date-parts":[[2006,8,25]],"date-time":"2006-08-25T18:15:54Z","timestamp":1156529754000},"page":"859-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson\u2019s disease"],"prefix":"10.1016","volume":"142","author":[{"given":"A.","family":"Raichur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Vali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2006.06.052_bib1","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1042\/bj20031466","article-title":"Bicarbonate enhances alpha-synuclein oligomerization and nitration: intermediacy of carbonate radical anion and nitrogen dioxide radical","volume":"378","author":"Andrekopoulos","year":"2004","journal-title":"Biochem J"},{"issue":"3","key":"10.1016\/j.neuroscience.2006.06.052_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/BF03033137","article-title":"Dopamine- or l-DOPA-induced neurotoxicity: the role of dopamine quinine formation and tyrosinase in a model of Parkinson\u2019s disease","volume":"5","author":"Asanuma","year":"2003","journal-title":"Neurotox Res"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib3","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1602\/neurorx.2.3.484","article-title":"Toxin-induced models of Parkinson\u2019s disease","volume":"2","author":"Bove","year":"2005","journal-title":"NeuroRx"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib4","doi-asserted-by":"crossref","first-page":"19738","DOI":"10.1074\/jbc.M100245200","article-title":"Modulation of cellular iron metabolism by hydrogen peroxide","volume":"276","author":"Caltagirone","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib5","doi-asserted-by":"crossref","first-page":"30009","DOI":"10.1074\/jbc.M501308200","article-title":"Alpha-synuclein alters proteasome function, protein synthesis, and stationary phase viability","volume":"280","author":"Chen","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib6","doi-asserted-by":"crossref","first-page":"7151","DOI":"10.1093\/emboj\/17.24.7151","article-title":"The ubiquitin-proteasome pathway: on protein death and cell life","volume":"17","author":"Ciechanover","year":"1998","journal-title":"EMBO J"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib7","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.2174\/0929867033456792","article-title":"Brain nitric oxide and its dual role in neurodegeneration\/neuroprotection: understanding molecular mechanisms to devise drug approaches","volume":"10","author":"Contestabile","year":"2003","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib8","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1021\/bi9723360","article-title":"Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes","volume":"37","author":"Dang","year":"1998","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib9","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1093\/brain\/114.4.1953","article-title":"Alterations in the levels of iron, ferritin and other trace metals in Parkinson\u2019s disease and other neurodegenerative diseases affecting the basal ganglia","volume":"114","author":"Dexter","year":"1991","journal-title":"Brain"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib10","doi-asserted-by":"crossref","first-page":"16619","DOI":"10.1074\/jbc.M413591200","article-title":"Alpha-synuclein and parkin contribute to the assembly of ubiquitin lysine 63-linked multiubiquitin chains","volume":"280","author":"Doss-Pepe","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib11","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.biopha.2003.11.004","article-title":"Neurodegenerative diseases and oxidative stress","volume":"58","author":"Emerit","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib12","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/archneur.62.3.353","article-title":"Molecular pathogenesis of Parkinson disease","volume":"62","author":"Eriksen","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0014-5793(94)01451-6","article-title":"A human de-ubiquitinating enzyme with both isopeptidase and peptidase activities in vitro","volume":"359","author":"Falquet","year":"1995","journal-title":"FEBS Lett"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib14","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jneumeth.2005.04.005","article-title":"Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson\u2019s disease: histological, neurochemical, motor and memory alterations","volume":"148","author":"Ferro","year":"2005","journal-title":"J Neurosci Methods"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib15","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/PL00007856","article-title":"The heterogeneity of idiopathic Parkinson\u2019s disease","volume":"249","author":"Foltynie","year":"2002","journal-title":"J Neurol"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0092-8674(03)00509-9","article-title":"Are ubiquitination pathways central to Parkinson\u2019s disease?","volume":"114","author":"Giasson","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib17","doi-asserted-by":"crossref","first-page":"28233","DOI":"10.1074\/jbc.274.40.28233","article-title":"Bicarbonate enhances the peroxidase activity of Cu, Zn-superoxide dismutase","volume":"274","author":"Goss","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/abbi.1996.0362","article-title":"Carbon dioxide enhancement of peroxynitrite-mediated protein tyrosine nitration","volume":"333","author":"Gow","year":"1996","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib19","doi-asserted-by":"crossref","first-page":"RE6","DOI":"10.1126\/sageke.2003.34.re6","article-title":"Ubiquitin, proteasomes, and the aging brain","volume":"2003","author":"Gray","year":"2003","journal-title":"Sci Aging Knowledge Environ"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib20","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S0092-8674(04)00343-5","article-title":"Balancing acts: molecular control of mammalian iron metabolism","volume":"117","author":"Hentze","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1749-6632.2003.tb07466.x","article-title":"Oxidative modifications of alpha-synuclein","volume":"991","author":"Ischiropoulos","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib22","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1523\/JNEUROSCI.22-07-02780.2002","article-title":"Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system","volume":"22","author":"Kirik","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib23","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/33416","article-title":"Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism","volume":"392","author":"Kitada","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1074\/jbc.M107045200","article-title":"Membrane-bound alpha-synuclein has a high aggregation propensity and the ability to seed the aggregation of the cytosolic form","volume":"277","author":"Lee","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib25","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1523\/JNEUROSCI.3809-03.2004","article-title":"Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway","volume":"24","author":"Lee","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib26","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s11910-005-0064-6","article-title":"Genetics of parkinsonism","volume":"5","author":"Lewthwaite","year":"2005","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib27","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.neurobiolaging.2005.08.012","article-title":"Protein aggregation in the pathogenesis of familial and sporadic Parkinson\u2019s disease","volume":"27","author":"McNaught","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/ana.20186","article-title":"Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson\u2019s disease","volume":"56","author":"McNaught","year":"2004","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib29","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0006-8993(02)03514-X","article-title":"Lysosomal malfunction accompanies alpha-synuclein aggregation in a progressive mouse model of Parkinson\u2019s disease","volume":"956","author":"Meredith","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib30","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1212\/01.WNL.0000127517.33208.F4","article-title":"Alpha-synuclein in blood and brain from familial Parkinson disease with SNCA locus triplication","volume":"62","author":"Miller","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib31","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1093\/hmg\/ddh012","article-title":"Parkin is recruited into aggresomes in a stress-specific manner: over-expression of parkin reduces aggresome formation but can be dissociated from parkin\u2019s effect on neuronal survival","volume":"13","author":"Muqit","year":"2004","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib32","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0006-291X(03)00555-2","article-title":"Alterations of structure and hydrolase activity of parkinsonism-associated human ubiquitin carboxyl-terminal hydrolase L1 variants","volume":"304","author":"Nishikawa","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib33","doi-asserted-by":"crossref","first-page":"8053","DOI":"10.1523\/JNEUROSCI.21-20-08053.2001","article-title":"Induction of alpha-synuclein aggregation by intracellular nitrative insult","volume":"21","author":"Paxinou","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib34","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/S0306-4522(97)00347-3","article-title":"Differential compartmentalization of brain ascorbate and glutathione between neurons and glia","volume":"82","author":"Rice","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib35","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jnr.20446","article-title":"Lysosomal pathology associated with alpha-synuclein accumulation in transgenic models using an eGFP fusion protein","volume":"80","author":"Rockenstein","year":"2005","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib36","doi-asserted-by":"crossref","first-page":"34576","DOI":"10.1074\/jbc.274.49.34576","article-title":"Evidence against the generation of free hydroxyl radicals from the interaction of copper, zinc-superoxide dismutase and hydrogen peroxide","volume":"274","author":"Sankarapandi","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib37","doi-asserted-by":"crossref","first-page":"4904","DOI":"10.1046\/j.1432-1327.2000.01595.x","article-title":"Glutathione, oxidative stress and neurodegeneration","volume":"267","author":"Schulz","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib38","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib39","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/ana.410360305","article-title":"Alterations in glutathione levels in Parkinson\u2019s disease and other neurodegenerative disorders affecting basal ganglia","volume":"36","author":"Sian","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib40","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/ana.410360306","article-title":"Glutathione-related enzymes in brain in Parkinson\u2019s disease","volume":"36","author":"Sian","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib41","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1196\/annals.1332.016","article-title":"The role of {alpha}-synuclein in both neuroprotection and neurodegeneration","volume":"1035","author":"Sidhu","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib42","doi-asserted-by":"crossref","first-page":"7562","DOI":"10.1074\/jbc.M412887200","article-title":"beta-Synuclein reduces proteasomal inhibition by alpha-synuclein but not gamma-synuclein","volume":"280","author":"Snyder","year":"2005","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib43","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF01244786","article-title":"Increased iron (III) and total iron content in postmortem substantia nigra of Parkinsonian brain","volume":"74","author":"Sofic","year":"1988","journal-title":"J Neural Transm"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib44","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00004647-200202000-00011","article-title":"Increase in dopamine turnover occurs early in Parkinson\u2019s disease: evidence from a new modeling approach to PET 18 F-fluorodopa data","volume":"22","author":"Sossi","year":"2002","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib45","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1073\/pnas.86.4.1398","article-title":"Dopamine turnover and glutathione oxidation: implications for Parkinson disease","volume":"86","author":"Spina","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib46","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S1474-4422(05)70177-0","article-title":"Pathological gambling in Parkinson\u2019s disease","volume":"4","author":"Stocchi","year":"2005","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib47","doi-asserted-by":"crossref","first-page":"6221","DOI":"10.1046\/j.1432-1327.2000.01706.x","article-title":"Kinetic evidences for facilitation of peptide channelling by the proteasome activator PA28","volume":"267","author":"Stohwasser","year":"2000","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib48","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1124\/mol.66.1.70","article-title":"In silico simulation of inhibitor drug effects on nuclear factor-kappaB pathway dynamics","volume":"66","author":"Sung","year":"2004","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0753-3322(03)00043-X","article-title":"The importance of glutathione in human disease","volume":"57","author":"Townsend","year":"2003","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib50","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.molbrainres.2004.11.014","article-title":"Effects of nitration on the structure and aggregation of alpha-synuclein","volume":"134","author":"Uversky","year":"2005","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib51","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1093\/aje\/kwg068","article-title":"Incidence of Parkinson\u2019s disease: variation by age, gender, and race\/ethnicity","volume":"157","author":"Van Den Eeden","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib52","doi-asserted-by":"crossref","first-page":"24766","DOI":"10.1016\/S0021-9258(19)74530-X","article-title":"Multiubiquitin chains linked through lysine 48 are abundant in vivo and are competent intermediates in the ubiquitin proteolytic pathway","volume":"268","author":"van Nocker","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib53","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1023\/A:1026501515450","article-title":"Steady-state kinetic analysis of human ubiquitin-activating enzyme (E1) using a fluorescently labeled ubiquitin substrate","volume":"19","author":"Wee","year":"2000","journal-title":"J Protein Chem"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib54","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00439-003-1074-6","article-title":"Genetics of parkin-linked disease","volume":"114","author":"West","year":"2004","journal-title":"Hum Genet"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib55","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1177\/107385840200800107","article-title":"Iron and Parkinson\u2019s disease","volume":"8","author":"Wolozin","year":"2002","journal-title":"Neuroscientist"},{"key":"10.1016\/j.neuroscience.2006.06.052_bib56","doi-asserted-by":"crossref","first-page":"16504","DOI":"10.1016\/S0021-9258(19)85448-0","article-title":"Generation of reactive oxygen species during the monoamine oxidase-catalyzed oxidation of the neurotoxicant, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"268","author":"Zang","year":"1993","journal-title":"J Biol Chem"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452206008621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306452206008621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T15:27:09Z","timestamp":1759678029000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306452206008621"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,10]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,10]]}},"alternative-id":["S0306452206008621"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2006.06.052","relation":{},"ISSN":["0306-4522"],"issn-type":[{"type":"print","value":"0306-4522"}],"subject":[],"published":{"date-parts":[[2006,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamic modeling of alpha-synuclein aggregation for the sporadic and genetic forms of Parkinson\u2019s disease","name":"articletitle","label":"Article Title"},{"value":"Neuroscience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuroscience.2006.06.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2006 IBRO. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}